BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11174098)

  • 1. [Plasma homocysteine measurement: a study of pre-analytical variation factors for conditions for total plasma homocysteine concentration].
    Ducros V; Candito M; Caussé E; Couderc R; Demuth K; Diop ME; Drai J; Gachon AM; Garcia I; Gerhardt MF; Philippe-Bourgeois C; Read MH; Sauvant MP
    Ann Biol Clin (Paris); 2001; 59(1):33-9. PubMed ID: 11174098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of plasma total homocysteine concentrations in EDTA-whole blood kept on ice.
    Korzun WJ; Ho QV
    Clin Lab Sci; 2000; 13(4):196-8. PubMed ID: 11586504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of some pre-analytical conditions on the measurement of homocysteine and cysteine in plasma.
    Zighetti ML; Chantarangkul V; Lombardi R; Lecchi A; Cattaneo M
    Clin Chem Lab Med; 2004 Feb; 42(2):204-7. PubMed ID: 15061362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of anticoagulants on plasma homocysteine determination.
    Calişkan S; Kuralay F; Onvural B
    Clin Chim Acta; 2001 Jul; 309(1):53-6. PubMed ID: 11408006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine and its determinants in nondialyzed chronic kidney disease patients.
    Nerbass FB; Draibe SA; Feiten SF; Chiarello PG; Vannucchi H; Cuppari L
    J Am Diet Assoc; 2006 Feb; 106(2):267-70. PubMed ID: 16442876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion.
    Di Crecchio L; Parodi MB; Sanguinetti G; Iacono P; Ravalico G
    Ophthalmology; 2004 May; 111(5):940-5. PubMed ID: 15121372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Better stability of total homocysteine measurement with sodium fluoride than with EDTA.
    Wolff F; Gausset P; Vanderpas J
    Clin Lab; 2005; 51(5-6):275-8. PubMed ID: 15991800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of citrate buffer-fluoride mixture in Terumo tubes as an inhibitor of in vitro glycolysis.
    Bonetti G; Carta M; Montagnana M; Lo Cascio C; Bonfigli AR; Mosca A; Testa R;
    Biochem Med (Zagreb); 2016; 26(1):68-76. PubMed ID: 26981020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects.
    Ventura P; Panini R; Verlato C; Scarpetta G; Salvioli G
    Metabolism; 2001 Dec; 50(12):1466-71. PubMed ID: 11735095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated plasma homocysteine and low vitamin B-6 status in nonsupplementing older women with rheumatoid arthritis.
    Woolf K; Manore MM
    J Am Diet Assoc; 2008 Mar; 108(3):443-53; discussion 454. PubMed ID: 18313425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of pre-analytical and analytical factors on soluble CD40L measurements.
    Varo N; Nuzzo R; Natal C; Libby P; Schönbeck U
    Clin Sci (Lond); 2006 Nov; 111(5):341-7. PubMed ID: 16856875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V; Kes P; Reiner Z
    Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complement activation in citrate plasma--inhibitory effect of anticoagulants on serum complement activation].
    Kobayashi E; Kitano E; Kondo H; Kitamura H
    Rinsho Byori; 1999 Feb; 47(2):160-4. PubMed ID: 10097633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of whole blood and plasma ascorbic acid.
    Karlsen A; Blomhoff R; Gundersen TE
    Eur J Clin Nutr; 2007 Oct; 61(10):1233-6. PubMed ID: 17299479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relation between plasma homocysteine level and cardiovascular risk factors in cerebral ischemia.
    Huang CW; Chen TH; Lin HS; Tseng YL; Lai SL; Chen WH; Chen SS; Liu JS
    Acta Neurol Taiwan; 2007 Jun; 16(2):81-5. PubMed ID: 17685131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-analytical conditions affecting the determination of the plasma homocysteine concentration.
    Nauck M; Bisse E; Nauck M; Wieland H
    Clin Chem Lab Med; 2001 Aug; 39(8):675-80. PubMed ID: 11592432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma homocysteine levels in patients with ischemic heart disease].
    Márk L; Erdei F; Márki-Zay J; Nagy E; Kondacs A; Katona A
    Orv Hetil; 2001 Jul; 142(30):1611-5. PubMed ID: 11519232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retinal vein occlusion and hyperhomocysteinemia].
    Blondel J; Glacet-Bernard A; Bayani N; Blacher J; Lelong F; Nordmann JP; Coscas G; Soubrane G
    J Fr Ophtalmol; 2003 Mar; 26(3):249-53. PubMed ID: 12746600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between creatinine clearance and plasma homocysteine levels in predialytic chronic renal failure patients.
    Widiana IG; Suwitra K
    Acta Med Indones; 2004; 36(1):15-8. PubMed ID: 15931697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.